EUVIMEDEUVIMED entdecken
Crossref

[ 90 Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to “TheraSphere” for Cost-Effective Treatment of Liver Cancer

K V Vimalnath, Ardhi Rajeswari, Anupam Dixit, Rubel Chakravarty, Haldhar D Sarma, Suyash Kulkarni, Ashish Jha, Ameya Puranik, Venkatesh Rangarajan, Madhumita Goswami, Sudipta Chakraborty iD

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2023.0118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von K V Vimalnath und 10 weiteren Autor:innen. Beteiligte Einrichtung: Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai, India. Hauptthemen laut MEDLINE: Biosimilar Pharmaceuticals, Liver Neoplasms, Carcinoma, Hepatocellular, Embolization, Therapeutic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosimilar PharmaceuticalsLiver NeoplasmsCarcinoma, HepatocellularEmbolization, TherapeuticYttriumRatsAnimalsHumansMicrospheresRats, WistarTissue DistributionCost-Benefit AnalysisYttrium RadioisotopesRadiopharmaceuticals

Stichwörter der Autor:innen

90YSIRTbiosimilarglass microspheresliver carcinomayttria alumino silicate

Substanzen

Yttrium-90yttriaBiosimilar PharmaceuticalsYttrium RadioisotopesRadiopharmaceuticalsYttrium

Autor:innen und Institutionen

  • Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai, India.
  • Glass and Advance Materials Division, Bhabha Atomic Research Centre, Trombay, Mumbai, India.
  • Homi Bhabha National Institute, Anushaktinagar, Mumbai, India.
  • Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai, India.
  • Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Centre, Parel, Mumbai, India.

ORCID-Profile: Sudipta Chakraborty

Zitieren

APA

Vimalnath, K. V., Rajeswari, A., Dixit, A., Chakravarty, R., Sarma, H. D., Kulkarni, S., Jha, A., Puranik, A., Rangarajan, V., Goswami, M., & Chakraborty, S. (2024). [ 90 Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to “TheraSphere” for Cost-Effective Treatment of Liver Cancer. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0118

Vancouver

Vimalnath KV, Rajeswari A, Dixit A, Chakravarty R, Sarma HD, Kulkarni S, et al. [ 90 Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to “TheraSphere” for Cost-Effective Treatment of Liver Cancer. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0118

BibTeX
@article{Vimalnath2024,
  author = {Vimalnath, K V and Rajeswari, Ardhi and Dixit, Anupam and Chakravarty, Rubel and Sarma, Haldhar D and Kulkarni, Suyash and Jha, Ashish and Puranik, Ameya and Rangarajan, Venkatesh and Goswami, Madhumita and Chakraborty, Sudipta},
  title = {[ 90 Y]Yttria Alumino Silicate Glass Microspheres: A Biosimilar Formulation to “TheraSphere” for Cost-Effective Treatment of Liver Cancer},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2023.0118}
}
Kostenlos starten →